Skip to main content
Erschienen in: Annals of Surgical Oncology 12/2007

01.12.2007 | Gynecologic Oncology

Surgical Management of Mesenteric Lymph Node Metastasis in Patients Undergoing Rectosigmoid Colectomy for Locally Advanced Ovarian Carcinoma

verfasst von: Ritu Salani, MD, Teresa Diaz-Montes, MPH MD, Robert L. Giuntoli, II MD, Robert E. Bristow, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 12/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

We sought to determine the incidence of mesenteric lymph node metastases in patients undergoing rectosigmoid resection for epithelial ovarian carcinoma and to evaluate the potential contribution of sigmoid mesocolectomy toward achieving complete surgical cytoreduction.

Methods

Pathology results for patients undergoing rectosigmoid colectomy for epithelial ovarian carcinoma from August 1998 through September 2005 were retrospectively reviewed. Fifty-three patients with pathological documentation of mesenteric lymph nodes were selected for further review. A focused analysis was performed on cases with an adequate surgical sampling of mesenteric lymph nodes (more than one positive or five total mesenteric lymph nodes) to determine the overall incidence of nodal metastases. χ2 analysis was used to identify clinicopathologic factors associated with mesenteric lymphatic spread.

Results

A total of 39 (73.6%) of 53 patients had an adequate mesenteric resection suitable for nodal analysis. In this subgroup, 32 (82.1%) of 39 patients had one or more mesenteric lymph nodes containing metastatic ovarian carcinoma. Invasion beyond the serosa of the rectosigmoid colon was present in 31 (79.5%) of 39 of cases; however, increasing depth of invasion was not associated with risk of mesenteric nodal disease. In addition to bowel wall involvement, the only clinical factor that correlated with mesenteric lymph node involvement was concurrent tumor spread to retroperitoneal lymph nodes (P = .025).

Conclusions

Locally advanced ovarian carcinoma involving the rectosigmoid colon is associated with a high incidence of mesenteric nodal metastasis. Standard surgical technique should include a sigmoid mesocolectomy with resection of the associated lymphatic tributaries at the time of rectosigmoid colectomy if the surgical objective is complete cytoreduction of occult nodal disease.
Literatur
1.
Zurück zum Zitat Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43–66PubMedCrossRef Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43–66PubMedCrossRef
2.
Zurück zum Zitat Ozols RF, Rubin SC, Thomas GM, Robboy SJ. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC, Barakat RR, Markman M, Randall ME, ed. Principles and Practices of Gynecologic Oncology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2005:895–977 Ozols RF, Rubin SC, Thomas GM, Robboy SJ. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC, Barakat RR, Markman M, Randall ME, ed. Principles and Practices of Gynecologic Oncology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2005:895–977
3.
Zurück zum Zitat Chi DS, Liao JB, Leon LF, et al. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol 2001;82:532–7PubMedCrossRef Chi DS, Liao JB, Leon LF, et al. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol 2001;82:532–7PubMedCrossRef
4.
Zurück zum Zitat Hoskins WJ, McGuire WP, Brady MF, et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994;170:974–80PubMed Hoskins WJ, McGuire WP, Brady MF, et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994;170:974–80PubMed
5.
Zurück zum Zitat Scarabelli C, Gallo A, Franceschi S, et al. Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinoma. Cancer 2000;88:389–97PubMedCrossRef Scarabelli C, Gallo A, Franceschi S, et al. Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinoma. Cancer 2000;88:389–97PubMedCrossRef
6.
Zurück zum Zitat Eisenkop SM, Spirtos NM, Friedman RL, Lin WC, Pisani AL, Perticucci S. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol 2003;90:390–6PubMedCrossRef Eisenkop SM, Spirtos NM, Friedman RL, Lin WC, Pisani AL, Perticucci S. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol 2003;90:390–6PubMedCrossRef
7.
Zurück zum Zitat Weber AM, Kennedy AW. The role of bowel resection in the primary surgical debulking of carcinoma of the ovary. J Am Coll Surg 1994;179:465–70PubMed Weber AM, Kennedy AW. The role of bowel resection in the primary surgical debulking of carcinoma of the ovary. J Am Coll Surg 1994;179:465–70PubMed
8.
Zurück zum Zitat Eisenkop SM, Friedman RL, Spirtos NM. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 2000;88:144–53PubMedCrossRef Eisenkop SM, Friedman RL, Spirtos NM. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 2000;88:144–53PubMedCrossRef
9.
Zurück zum Zitat Bristow RE, del Carmen MG, Kaufman HS, Montz FJ. Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer. J Am Coll Surg 2003;197:565–74PubMedCrossRef Bristow RE, del Carmen MG, Kaufman HS, Montz FJ. Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer. J Am Coll Surg 2003;197:565–74PubMedCrossRef
10.
Zurück zum Zitat Spirtos NM, Eisenkop SM, Schlaerth JB, Ballon SC. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer. Am J Obstet Gynecol 2000;182:1321–7PubMedCrossRef Spirtos NM, Eisenkop SM, Schlaerth JB, Ballon SC. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer. Am J Obstet Gynecol 2000;182:1321–7PubMedCrossRef
11.
Zurück zum Zitat Mourton SM, Temple LK, Abu-Rustum NR, et al. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol 2005 Mourton SM, Temple LK, Abu-Rustum NR, et al. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol 2005
12.
Zurück zum Zitat Berek JS, Hacker NF, Lagasse LD. Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer. Obstet Gynecol 1984;64:715–20PubMed Berek JS, Hacker NF, Lagasse LD. Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer. Obstet Gynecol 1984;64:715–20PubMed
13.
Zurück zum Zitat Tamussino KF, Lim PC, Webb MJ, Lee RA, Lesnick TG. Gastrointestinal surgery in patients with ovarian cancer. Gynecol Oncol 2001;80:79–84PubMedCrossRef Tamussino KF, Lim PC, Webb MJ, Lee RA, Lesnick TG. Gastrointestinal surgery in patients with ovarian cancer. Gynecol Oncol 2001;80:79–84PubMedCrossRef
14.
Zurück zum Zitat Hoffman MS, Griffin D, Tebes S, et al. Sites of bowel resected to achieve optimal ovarian cancer cytoreduction: implications regarding surgical management. Am J Obstet Gynecol 2005;193:582–6PubMedCrossRef Hoffman MS, Griffin D, Tebes S, et al. Sites of bowel resected to achieve optimal ovarian cancer cytoreduction: implications regarding surgical management. Am J Obstet Gynecol 2005;193:582–6PubMedCrossRef
15.
Zurück zum Zitat Hertel H, Diebolder H, Herrmann J, et al. Is the decision for colorectal resection justified by histopathologic findings: a prospective study of 100 patients with advanced ovarian cancer. Gynecol Oncol 2001;83:481–4PubMedCrossRef Hertel H, Diebolder H, Herrmann J, et al. Is the decision for colorectal resection justified by histopathologic findings: a prospective study of 100 patients with advanced ovarian cancer. Gynecol Oncol 2001;83:481–4PubMedCrossRef
16.
Zurück zum Zitat Heintz AP, Hacker NF, Berek JS, Rose TP, Munoz AK, Lagasse LD. Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity. Obstet Gynecol 1986;67:783–8PubMedCrossRef Heintz AP, Hacker NF, Berek JS, Rose TP, Munoz AK, Lagasse LD. Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity. Obstet Gynecol 1986;67:783–8PubMedCrossRef
17.
Zurück zum Zitat Adenocarcinoma of the colon and rectum. In: Kufe DW, Pollock RE, Weicheselbaum RR, Bast RC Jr, Holland JF, Frei E III. Cancer Medicine 6. London: BC Decker, 2003 Adenocarcinoma of the colon and rectum. In: Kufe DW, Pollock RE, Weicheselbaum RR, Bast RC Jr, Holland JF, Frei E III. Cancer Medicine 6. London: BC Decker, 2003
18.
19.
Zurück zum Zitat Cecil TD, Sexton R, Moran BJ, Heald RJ. Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum 2004;47:1145–9PubMedCrossRef Cecil TD, Sexton R, Moran BJ, Heald RJ. Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum 2004;47:1145–9PubMedCrossRef
20.
Zurück zum Zitat Enker WE. Total mesorectal excision—the new golden standard of surgery for rectal cancer. Ann Med 1997;29:127–33PubMed Enker WE. Total mesorectal excision—the new golden standard of surgery for rectal cancer. Ann Med 1997;29:127–33PubMed
21.
Zurück zum Zitat MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341(8843):457–60PubMedCrossRef MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341(8843):457–60PubMedCrossRef
22.
Zurück zum Zitat O’Hanlan KA, Kargas S, Schreiber M, et al. Ovarian carcinoma metastases to gastrointestinal tract appear to spread like colon carcinoma: implications for surgical resection. Gynecol Oncol 1995;59:200–6PubMedCrossRef O’Hanlan KA, Kargas S, Schreiber M, et al. Ovarian carcinoma metastases to gastrointestinal tract appear to spread like colon carcinoma: implications for surgical resection. Gynecol Oncol 1995;59:200–6PubMedCrossRef
23.
Zurück zum Zitat Sonnendecker EW, Beale PG. Rectosigmoid resection without colostomy during primary cytoreductive surgery for ovarian carcinoma. Int Surg 1989;74:10–2PubMed Sonnendecker EW, Beale PG. Rectosigmoid resection without colostomy during primary cytoreductive surgery for ovarian carcinoma. Int Surg 1989;74:10–2PubMed
24.
Zurück zum Zitat Miller J, Proietto A. The place of bowel resection in initial debulking surgery for advanced ovarian cancer. Aust N Z J Obstet Gynaecol 2002;42:535–7PubMedCrossRef Miller J, Proietto A. The place of bowel resection in initial debulking surgery for advanced ovarian cancer. Aust N Z J Obstet Gynaecol 2002;42:535–7PubMedCrossRef
25.
Zurück zum Zitat Clayton RD, Obermair A, Hammond IG, Leung YC, McCartney AJ. The Western Australian experience of the use of en bloc resection of ovarian cancer with concomitant rectosigmoid colectomy. Gynecol Oncol 2002;84:53–7PubMedCrossRef Clayton RD, Obermair A, Hammond IG, Leung YC, McCartney AJ. The Western Australian experience of the use of en bloc resection of ovarian cancer with concomitant rectosigmoid colectomy. Gynecol Oncol 2002;84:53–7PubMedCrossRef
26.
Zurück zum Zitat Bridges JE, Leung YC, Hammond IG, McCartney AJ. En bloc resection of epithelial ovarian tumors with concomitant rectosigmoid colectomy: the KEMH experience. Int J Gynecol Cancer 1993;3:199–202PubMedCrossRef Bridges JE, Leung YC, Hammond IG, McCartney AJ. En bloc resection of epithelial ovarian tumors with concomitant rectosigmoid colectomy: the KEMH experience. Int J Gynecol Cancer 1993;3:199–202PubMedCrossRef
27.
Zurück zum Zitat Soper JT, Couchman G, Berchuck A, Clarke-Pearson D. The role of partial sigmoid colectomy for debulking epithelial ovarian carcinoma. Gynecol Oncol 1991;41:239–44PubMedCrossRef Soper JT, Couchman G, Berchuck A, Clarke-Pearson D. The role of partial sigmoid colectomy for debulking epithelial ovarian carcinoma. Gynecol Oncol 1991;41:239–44PubMedCrossRef
28.
Zurück zum Zitat Jaeger W, Ackermann S, Kessler H, Katalinic A, Lang N. The effect of bowel resection on survival in advanced epithelial ovarian cancer. Gynecol Oncol 2001;83:286–91PubMedCrossRef Jaeger W, Ackermann S, Kessler H, Katalinic A, Lang N. The effect of bowel resection on survival in advanced epithelial ovarian cancer. Gynecol Oncol 2001;83:286–91PubMedCrossRef
29.
Zurück zum Zitat Gillette-Cloven N, Burger RA, Monk BJ, et al. Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer. J Am Coll Surg 2001;193:626–32PubMedCrossRef Gillette-Cloven N, Burger RA, Monk BJ, et al. Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer. J Am Coll Surg 2001;193:626–32PubMedCrossRef
30.
Zurück zum Zitat Abrams H, Spiro R, Goldstein N. Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer 1950;3:74–85PubMedCrossRef Abrams H, Spiro R, Goldstein N. Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer 1950;3:74–85PubMedCrossRef
31.
Zurück zum Zitat Dvoretsky PM, Richards KA, Angel C, et al. Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol 1988;19:57–63PubMedCrossRef Dvoretsky PM, Richards KA, Angel C, et al. Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol 1988;19:57–63PubMedCrossRef
32.
Zurück zum Zitat Iurkova LE, Vinokurov VL. [Lymphogenic dissemination of ovarian cancer based on autopsy data]. Vopr Onkol 1982;28:34–8PubMed Iurkova LE, Vinokurov VL. [Lymphogenic dissemination of ovarian cancer based on autopsy data]. Vopr Onkol 1982;28:34–8PubMed
33.
Zurück zum Zitat Kataoka A, Nishida T, Sugiyama T, Ushijima K, Ohta S, Kumagai S, Yakushiji M, Kojiro M, Morimatsu M. [A study on the distribution of metastases at autopsy in 70 patients with ovarian cancer]. Nippon Sanka Fujinka Gakkai Zasshi 1994;46:337–44PubMed Kataoka A, Nishida T, Sugiyama T, Ushijima K, Ohta S, Kumagai S, Yakushiji M, Kojiro M, Morimatsu M. [A study on the distribution of metastases at autopsy in 70 patients with ovarian cancer]. Nippon Sanka Fujinka Gakkai Zasshi 1994;46:337–44PubMed
34.
Zurück zum Zitat Lax SF, Petru E, Holzer E, Pertl AM, Ralph G, Greenspan DL, Bergers A, Jatzko G. Mesenteric and mesocolic lymph node metastases from ovarian carcinoma: a clinciopathological analysis. Int J Gynecol Cancer 1998;8:119–23CrossRef Lax SF, Petru E, Holzer E, Pertl AM, Ralph G, Greenspan DL, Bergers A, Jatzko G. Mesenteric and mesocolic lymph node metastases from ovarian carcinoma: a clinciopathological analysis. Int J Gynecol Cancer 1998;8:119–23CrossRef
Metadaten
Titel
Surgical Management of Mesenteric Lymph Node Metastasis in Patients Undergoing Rectosigmoid Colectomy for Locally Advanced Ovarian Carcinoma
verfasst von
Ritu Salani, MD
Teresa Diaz-Montes, MPH MD
Robert L. Giuntoli, II MD
Robert E. Bristow, MD
Publikationsdatum
01.12.2007
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 12/2007
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-007-9565-7

Weitere Artikel der Ausgabe 12/2007

Annals of Surgical Oncology 12/2007 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.